Centiva Capital’s Myriad Genetics MYGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-14,169	Closed	-$271K	–	1602
2023 Q4	$271K	Buy	+14,169	New	+$271K	0.01%	822
2023 Q2	–	Sell	-10,402	Closed	-$242K	–	1412
2023 Q1	$242K	Buy	+10,402	New	+$242K	0.01%	775